| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/11/2002 | CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | CA2434129A1 Degradation and detection of prion infectivity |
| 07/11/2002 | CA2434118A1 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | CA2433782A1 Proteins and nucleic acids encoding same |
| 07/11/2002 | CA2433781A1 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis |
| 07/11/2002 | CA2433749A1 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 07/11/2002 | CA2433579A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | CA2433559A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | CA2433446A1 Inhibitors of memapsin 2 and use thereof |
| 07/11/2002 | CA2433361A1 Controlled release systems for polymers |
| 07/11/2002 | CA2433332A1 Agents and methods for treating pain |
| 07/11/2002 | CA2433263A1 Stabilized pharmaceutical composition in lyophilized form |
| 07/11/2002 | CA2433225A1 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | CA2433041A1 Use of intermediate-conductance potassium channels and modulators for diagnosing and treating diseases involving disturbed keratinocyte activiyty |
| 07/11/2002 | CA2432853A1 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression |
| 07/11/2002 | CA2431662A1 A method for the manufacture of compositions containing low concentrations of salts |
| 07/11/2002 | CA2430667A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/10/2002 | EP1221615A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/10/2002 | EP1221490A2 Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars |
| 07/10/2002 | EP1221487A2 Polynucleotide molecules encoding neospora proteins |
| 07/10/2002 | EP1221486A2 Polynucleotide molecules encoding neospora proteins |
| 07/10/2002 | EP1221485A2 Polynucleotide molecules encoding neospora proteins |
| 07/10/2002 | EP1221484A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/10/2002 | EP1221483A1 NF-AT polypeptides and polynucleotides |
| 07/10/2002 | EP1221480A1 Polypeptide humanin inhibiting nerve cell death |
| 07/10/2002 | EP1221477A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/10/2002 | EP1221317A1 Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins |
| 07/10/2002 | EP1221316A1 Enteric-coated pharmaceutical compositions of mycophenolate |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220942A1 41 human secreted proteins |
| 07/10/2002 | EP1220938A1 Materials and methods for simplified aav production |
| 07/10/2002 | EP1220934A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 07/10/2002 | EP1220932A1 Human carboxypeptidases and polynucleotides encoding the same |
| 07/10/2002 | EP1220931A1 Dna encoding prost 07 polypeptide |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220925A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220921A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 07/10/2002 | EP1220920A1 The prv-1 gene and use thereof |
| 07/10/2002 | EP1220919A2 Metastasis-associated antigen c4.4a |
| 07/10/2002 | EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 07/10/2002 | EP1220916A1 Secreted factors |
| 07/10/2002 | EP1220913A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 07/10/2002 | EP1220911A2 P-glycoproteins and uses thereof |
| 07/10/2002 | EP1220910A1 Human organic anion transporter-like proteins and polynucleotides encoding the same |
| 07/10/2002 | EP1220909A2 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 07/10/2002 | EP1220908A2 Isolated peptides which bind to mhc class ii molecules, and uses thereof |
| 07/10/2002 | EP1220907A2 Human secretory molecules |
| 07/10/2002 | EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 07/10/2002 | EP1220905A2 Composition and methods for the treatment of immune related diseases |
| 07/10/2002 | EP1220903A1 Gene selection using pnas |
| 07/10/2002 | EP1220902A2 Conjugates between a peptide and a nucleic acid analog, such as a pna, lna or a morpholino |
| 07/10/2002 | EP1220901A1 26 human secreted proteins |
| 07/10/2002 | EP1220897A1 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 07/10/2002 | EP1220896A1 Novel human lipase proteins, nucleic acids encoding them, and uses of both of these |
| 07/10/2002 | EP1220895A1 Novel gene encoding a dna methyltransferase, dnmt3l |
| 07/10/2002 | EP1220887A1 Protein-containing granules and granule formulations |
| 07/10/2002 | EP1220873A1 Novel protein component and encoding nucleic acid |
| 07/10/2002 | EP1220872A1 Uroguanylin as an intestinal cancer inhibiting agent |
| 07/10/2002 | EP1220871A2 Substituted phosphinate based peptide derivatives |
| 07/10/2002 | EP1220870A1 Metal-binding compounds and uses therefor |
| 07/10/2002 | EP1220869A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 07/10/2002 | EP1220866A1 Antisense modulation of bcl-6 expression |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220864A1 Transgenically produced fusion proteins |
| 07/10/2002 | EP1220852A1 Substituted diazepans |
| 07/10/2002 | EP1220830A1 Systems and methods for opening obstructed biological conduits |
| 07/10/2002 | EP1220693A1 Formulations for delivery of osteogenic proteins |
| 07/10/2002 | EP1220690A2 Injection vehicle for polymer-based formulations |
| 07/10/2002 | EP1220685A2 Pharmaceutical compositions of fibrinolytic agent |
| 07/10/2002 | EP1220684A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/10/2002 | EP1220683A2 Mycophenolate mofetil in association with peg-ifn-alpha |
| 07/10/2002 | EP1220682A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 07/10/2002 | EP1220681A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 07/10/2002 | EP1220679A1 Cell-based gene therapy for the pulmonary system |
| 07/10/2002 | EP1220674A1 Pharmaceutical product suitable for use immunosuppressive therapy |
| 07/10/2002 | EP1220659A1 Pharmaceutical products and methods of fabrication therefor |
| 07/10/2002 | EP1220657A1 Liposome encapsulated silver salt compositions |
| 07/10/2002 | EP1220620A1 Composition comprising casein protein and whey protein |
| 07/10/2002 | EP1115420B1 Treatment of hepatitis b infection with thymosin alpha 1 and lamivudine |
| 07/10/2002 | EP1073451B1 Deltorphine for treating ischemia |
| 07/10/2002 | EP1071446B1 Regulation of ovarian maturation and function using epidermal growth factor |
| 07/10/2002 | EP0934427A4 Rh blood group antigen compositions and methods of use |
| 07/10/2002 | EP0914158B1 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 07/10/2002 | EP0812206B1 Cd40 binding protein for stimulating an immune response |
| 07/10/2002 | EP0698203B1 Composition comprising bradykinin for selective opening of abnormal brain tissue capillaries |
| 07/10/2002 | EP0679088B1 Pulmonary delivery of active fragments of parathyroid hormone |
| 07/10/2002 | EP0517805B1 Identification and expression of insect steroid receptor dna sequences |
| 07/10/2002 | CN1358228A Polynucleotide and deduced amino acid sequences from stromal cells |
| 07/10/2002 | CN1358227A Production of the lipidated form of the peptido glycon-associated lipoproteins of gram-negative bacteria |
| 07/10/2002 | CN1358195A Inhibitors of integrin alpha V beta 6 |
| 07/10/2002 | CN1358194A Streptogramin derivatives, preparation and compositions containing them |
| 07/10/2002 | CN1358187A New compounds |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1358174A New Compounds |
| 07/10/2002 | CN1358097A Anionic polymers as toxin binders and antibacterial agents |
| 07/10/2002 | CN1357631A Antiseptic WAP-8294A and WAP-8294AX and their prepn process and antiseptic composition |
| 07/10/2002 | CN1357384A Papaya-proteinase throat-moistening tablet |
| 07/10/2002 | CN1087346C RANTFS peptide and fragments for treatment of inflammation, and compositions with them |